Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies

被引:1
作者
Wang, Minkun [1 ,2 ]
Tsai, Tsung-Heng [1 ]
Di Poto, Cristina [1 ]
Ferrarini, Alessia [1 ]
Yu, Guoqiang [2 ]
Ressom, Habtom W. [1 ]
机构
[1] Georgetown Univ, Dept Oncol, 4000 Reservoir Rd NW, Washington, DC 20057 USA
[2] Virginia Tech, Dept Elect & Comp Engn, 900 N Glebe Rd, Arlington, VA USA
来源
BMC GENOMICS | 2016年 / 17卷
关键词
Bayesian inference; Topic model; Purification; LC-MS; GC-MS; Extracted ion chromatogram; Metabolomics; Proteomics; Biomarker discovery; IDENTIFICATION; PROTEOMICS; PROFILES;
D O I
10.1186/s12864-016-2796-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: A fundamental challenge in quantitation of biomolecules for cancer biomarker discovery is owing to the heterogeneous nature of human biospecimens. Although this issue has been a subject of discussion in cancer genomic studies, it has not yet been rigorously investigated in mass spectrometry based proteomic and metabolomic studies. Purification of mass spectometric data is highly desired prior to subsequent analysis, e.g., quantitative comparison of the abundance of biomolecules in biological samples. Methods: We investigated topic models to computationally analyze mass spectrometric data considering both integrated peak intensities and scan-level features, i.e., extracted ion chromatograms (EICs). Probabilistic generative models enable flexible representation in data structure and infer sample-specific pure resources. Scan-level modeling helps alleviate information loss during data preprocessing. We evaluated the capability of the proposed models in capturing mixture proportions of contaminants and cancer profiles on LC-MS based serum proteomic and GC-MS based tissue metabolomic datasets acquired from patients with hepatocellular carcinoma (HCC) and liver cirrhosis as well as synthetic data we generated based on the serum proteomic data. Results: The results we obtained by analysis of the synthetic data demonstrated that both intensity-level and scan-level purification models can accurately infer the mixture proportions and the underlying true cancerous sources with small average error ratios (< 7 %) between estimation and ground truth. By applying the topic model-based purification to mass spectrometric data, we found more proteins and metabolites with significant changes between HCC cases and cirrhotic controls. Candidate biomarkers selected after purification yielded biologically meaningful pathway analysis results and improved disease discrimination power in terms of the area under ROC curve compared to the results found prior to purification. Conclusions: We investigated topic model-based inference methods to computationally address the heterogeneity issue in samples analyzed by LC/GC-MS. We observed that incorporation of scan-level features have the potential to lead to more accurate purification results by alleviating the loss in information as a result of integrating peaks. We believe cancer biomarker discovery studies that use mass spectrometric analysis of human biospecimens can greatly benefit from topic model-based purification of the data prior to statistical and pathway analyses.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Machine Learning in Mass Spectrometric Analysis of DIA Data
    Xu, Leon L.
    Young, Adamo
    Zhou, Audrina
    Rost, Hannes L.
    PROTEOMICS, 2020, 20 (21-22)
  • [32] Topic Model-Based Micro-Blog User Interest Analysis
    Hu, Xinchen
    Zheng, Dequan
    Sun, Wanglong
    Li, Sheng
    2014 INTERNATIONAL CONFERENCE ON AUDIO, LANGUAGE AND IMAGE PROCESSING (ICALIP), VOLS 1-2, 2014, : 443 - 448
  • [33] Application of multiple statistical tests to enhance mass spectrometry-based biomarker discovery
    Tan, Niclas C.
    Fisher, Wayne G.
    Rosenblatt, Kevin P.
    Garner, Harold R.
    BMC BIOINFORMATICS, 2009, 10
  • [34] Mass Spectrometry-Based Approaches for Clinical Biomarker Discovery in Traumatic Brain Injury
    Creech, Matthew
    Carvalho, Lindsey
    McCoy, Heather
    Jacobs, Jon
    Hinson, H. E.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2022, 24 (12) : 605 - 618
  • [35] Lung Cancer Serum Biomarker Discovery Using Glycoprotein Capture and Liquid Chromatography Mass Spectrometry
    Zeng, Xuemei
    Hood, Brian L.
    Sun, Mai
    Conrads, Thomas P.
    Day, Roger S.
    Weissfeld, Joel L.
    Siegfried, Jill M.
    Bigbee, William L.
    JOURNAL OF PROTEOME RESEARCH, 2010, 9 (12) : 6440 - 6449
  • [36] Mass Spectrometric Discovery and Selective Reaction Monitoring (SRM) of Putative Protein Biomarker Candidates in First Trimester Trisomy 21 Maternal Serum
    Lopez, Mary F.
    Kuppusamy, Ramesh
    Sarracino, David A.
    Prakash, Amol
    Athanas, Michael
    Krastins, Bryan
    Rezai, Taha
    Sutton, Jennifer N.
    Peterman, Scott
    Nicolaides, Kypros
    JOURNAL OF PROTEOME RESEARCH, 2011, 10 (01) : 133 - 142
  • [37] Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform
    Schiffer, Eric
    Mischak, Harald
    Theodorescu, Dan
    Vlahou, Antonia
    WORLD JOURNAL OF UROLOGY, 2008, 26 (01) : 67 - 74
  • [38] Advances in mass spectrometry-based clinical biomarker discovery
    Christopher A. Crutchfield
    Stefani N. Thomas
    Lori J. Sokoll
    Daniel W. Chan
    Clinical Proteomics, 2016, 13
  • [39] Biomarker Signature Discovery from Mass Spectrometry Data
    Kong, Ao
    Gupta, Chinmaya
    Ferrari, Mauro
    Agostini, Marco
    Bedin, Chiara
    Bouamrani, Ali
    Tasciotti, Ennio
    Azencott, Robert
    IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2014, 11 (04) : 766 - 772
  • [40] Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform
    Eric Schiffer
    Harald Mischak
    Dan Theodorescu
    Antonia Vlahou
    World Journal of Urology, 2008, 26 : 67 - 74